Transforming Drug Discovery and the Lives of Patients

CN Bio is a leading bioengineering company specialising in single and multi-organ microphysiological systems and innovative lab technologies. We aim to provide systems that generate clinically translatable data that can enhance the development of tomorrow’s medicines.

5 Minute Guide to Human Organ-on-Chip Studies

Cells, Tissues, Organs and Multi-Organ Experiments

PhysioMimix Organ-on-Chip allows you to model human biology in the lab.

As a microphysiological system, it can be used to culture healthy or diseased tissue models, study multi-organ interactions and investigate ADME and toxicity.

Compact and Reliable

Compact and Reliable

CN Bio’s PhysioMimix™ OOC benchtop device quickly increases your in-lab capabilities. This Lab-on-a-Chip system uses advanced and diverse cell culture techniques, securing human-relevant pre-clinical data to boost your R&D success.

CN Bio expands service offering to support oncology drug discovery

New Oncology Service supports unique in vitro investigations into the PK/PD relationship Harnesses CN Bio’s proprietary PhysioMimix™ PK system Represents first implementation of intellectual...

CN Bio licenses human gut microbiome modelling tool from MIT and Northeastern University

Enables accurate modelling of the human colon and the mucosal barrier Provides new insights to the relationship between human microbiome and effect on human health Model to be integrated into CN...

Lonza and CN Bio Announce Distribution Agreement

Lonza and CN Bio Announce Distribution Agreement Providing Prevalidated Hepatocytes for Use on Innovative Organ-on-a-chip Range Through a new distribution agreement, Lonza will supply a selection of...

Of Mice and Men – Will human organ-on-a-chip disease models replace animal use?

The aim of organ-on-a-chip (OOC) technology is to more accurately replicate human physiology in vitro to overcome the relevance limitations of current approaches, and the field is progressing at a...

CN Bio’s PhysioMimix™ adopted by King’s College London to investigate chronic liver disease

Next generation organ-on-a-chip (OOC) technology to be used to investigate the human gut microbiome for improving outcomes for patients with liver cirrhosis Adoption follows successful collaboration...

Human organ
mimics

Powerful new
data

Translatable
results

COMPANY HEAD OFFICE INFORMATION:

332 Cambridge Science Park
Milton Road
Cambridge
CB4 0WN

+44 (0) 1223 737941
enquiries@cn-bio.com

FOR PRODUCT, SERVICES AND MARKETING ENQUIRIES:

+44 (0) 1223 737941
enquiries@cn-bio.com

CN BIO INNOVATIONS LIMITED REGISTERED OFFICE:

30 Upper High Street, Thame,
Oxfordshire, OX9 3EZ.

Registered No. 06517359.
VAT No. 978184563


    We like to contact you about: exciting events, campaigns and information about the new products (please note we DO NOT pass on your details to any other organisations), you can opt out of receiving communications at any time.
    By submitting your message, you acknowledge that you have read and understood the Privacy Policy

    I confirm that I would like CN Bio to stay in touch

      We like to contact you about: exciting events, campaigns and information about the new products (please note we DO NOT pass on your details to any other organisations), you can opt out of receiving communications at any time.
      By submitting your message, you acknowledge that you have read and understood the Privacy Policy

      I confirm that I would like CN Bio to stay in touch

        We like to contact you about: exciting events, campaigns and information about the new products (please note we DO NOT pass on your details to any other organisations), you can opt out of receiving communications at any time.
        By submitting your message, you acknowledge that you have read and understood the Privacy Policy

        I confirm that I would like CN Bio to stay in touch